DelMar Pharmaceuticals, Inc. Business Finance Contracts & Agreements
67 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Escrow Agreements (1)
- Exchange Agreements (2)
- Loan Agreements (1)
- Note Agreements (1)
- Purchase Agreements (9)
- Registration Rights Agreements (1)
- Stock Agreements (4)
- Subscription Agreements (5)
- Underwriting Agreements (3)
- Warrant Agreements (38)
- Asset Purchase Agreement, dated January 26, 2023, between TuHURA Biopharma Inc. and Morphogenesis, Inc (Filed With SEC on May 13, 2024)
- Form of Convertible Promissory Note issued in TuHURA Note Financing (Filed With SEC on May 13, 2024)
- Form of TuHURA Biosciences, Inc. Common Stock Warrant issued in TuHURA Note Financing (Filed With SEC on May 13, 2024)
- Form of Morphogenesis, Inc. Common Stock Purchase Warrant issued in Series B Preferred Stock Offering (Filed With SEC on May 13, 2024)
- Form of Morphogenesis, Inc. Common Stock Purchase Warrant issued in Note Conversion Transaction (Filed With SEC on May 13, 2024)
- Form of Morphogenesis, Inc. Common Stock Purchase Warrant issued in Series A-1 Preferred Stock Offering (Filed With SEC on May 13, 2024)
- Form of Morphogenesis, Inc. Common Stock Purchase Warrant, dated June 1, 2019, issued for advisory services (Filed With SEC on May 13, 2024)
- Form of Morphogenesis, Inc. Common Stock Purchase Warrant issued in Series A Preferred Offering (Filed With SEC on May 13, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 24, 2023)
- Form of Placement Agent Warrant (Filed With SEC on October 24, 2023)
- Form of Common Warrant (Filed With SEC on October 24, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 24, 2023)
- Registration Rights Agreement, dated as of August 2, 2022, by and between Kintara Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2022)
- Purchase Agreement, dated as of August 2, 2022, by and between Kintara Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2022)
- Form of Securities Purchase Agreement, dated April 12, 2022, by and between Kintara Therapeutics, Inc. and the purchasers named therein (Filed With SEC on April 13, 2022)
- Form of Placement Agent Warrant (Filed With SEC on April 13, 2022)
- Form of Investor Warrant (Filed With SEC on April 13, 2022)
- Form of Securities Purchase Agreement, dated September 23, 2021 (Filed With SEC on September 28, 2021)
- Form of Wainwright Warrant (Filed With SEC on September 28, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on September 28, 2021)
- Form of Investor Warrant (Filed With SEC on September 28, 2021)
- Form of Placement Agent Warrant (Filed With SEC on September 1, 2020)
- Form of Subscription Agreement (Filed With SEC on August 21, 2020)
- Amendment to Asset Purchase Agreement, dated as of May 12, 2014, by and between Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC (Filed With SEC on June 16, 2020)
- Asset Purchase Agreement, dated as of November 26, 2012, by and between Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC (Filed With SEC on June 16, 2020)
- Underwriting Agreement, dated as of August 14, 2019, by and among DelMar Pharmaceuticals, Inc., Maxim Group LLC and Dawson James Securities, Inc (Filed With SEC on August 15, 2019)
- Warrant Agency Agreement, dated as of August 14, 2019, by and between DelMar Pharmaceuticals, Inc. and Mountain Share Transfer, LLC (Filed With SEC on August 15, 2019)
- Form of Underwriter Warrant (Filed With SEC on August 15, 2019)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on August 15, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on August 15, 2019)
- Form of Warrant Agency Agreement (Filed With SEC on August 12, 2019)
- Form of Underwriters Warrant (Filed With SEC on August 12, 2019)
- Form of Pre-Funded Warrant Certificate (Filed With SEC on August 12, 2019)
- Form of Warrant Certificate (Filed With SEC on August 12, 2019)
- Form of Underwriting Agreement (Filed With SEC on August 12, 2019)
- Form of Purchase Agreement, dated as of June 3, 2019 among DelMar Pharmaceuticals, Inc. and the purchasers thereunder (Filed With SEC on June 3, 2019)
- Form of Placement Agent Warrant (Filed With SEC on June 3, 2019)
- Form of Investor Warrant (Filed With SEC on June 3, 2019)
- Form of Dealer-Manager Warrant Certificate (Filed With SEC on May 23, 2019)
- Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on May 23, 2019)
